Preventive and Therapeutic Vaccine Market Analysis by Product and Segment Forecasts, 2017 - 2024 - PowerPoint PPT Presentation

Loading...

PPT – Preventive and Therapeutic Vaccine Market Analysis by Product and Segment Forecasts, 2017 - 2024 PowerPoint presentation | free to download - id: 87d618-Y2QwN



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Preventive and Therapeutic Vaccine Market Analysis by Product and Segment Forecasts, 2017 - 2024

Description:

Soaring prevalence of diseases among children is resulting in the implementation of awareness programs by governments across the globe. Moreover, significant advancements in vaccinology, such as the emergence, development, and usage of hepatitis B vaccine, should augment the business growth over the coming years. – PowerPoint PPT presentation

Number of Views:7

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Preventive and Therapeutic Vaccine Market Analysis by Product and Segment Forecasts, 2017 - 2024


1
Preventive and Therapeutic Vaccine Market Size,
Industry Analysis Report, Regional Outlook-
2017-2024. Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
Low Power Wide Area Network
2
Application of Chemical Anal Preventive and
Therapeutic Vaccine yzers Market
  • Increasing government funding for vaccine
    development, rising RD investments, the
    introduction of faster vaccine development
    technologies, and improvements in vaccine design
    are some of the factors, which will fuel market
    growth over the coming years. However, the high
    cost of vaccine storage and transportation and
    stringent regulations for the approval of
    vaccines will hamper the market expansion.
  • Global preventive and therapeutic vaccine market
    is broadly classified into preventive vaccine
    market and therapeutic vaccine market. Based on
    the product type, preventive vaccine market is
    segmented into pediatric and adult vaccines and
    therapeutic vaccine is segmented into
    neurological disease vaccines, autoimmune disease
    vaccines, infectious disease vaccines, and cancer
    vaccines.

3
Key Vendors of Preventive and Therapeutic Vaccine
Market
  • Some of the major players in the global
    preventive and therapeutic vaccine market are
    Sanofi Pasteur, Merck Co., Pfizer, and
    GlaxoSmithKline.
  • The largest players account for approximately 80
    of the global revenue. AstraZeneca, Johnson
    Johnson, CSL, and Emergent Biosolutions are the
    other notable industry players.

4
Regional Analysis of Preventive and Therapeutic
Vaccine Market
  • Latin America therapeutic vaccines targeting
    cancers and allergies offer vast opportunities
    for fresh players entering this regional market.
    First FDA-approved therapeutic vaccine, Provenge
    by Dendreon, treating prostate cancer
    acknowledged the potential of vaccines in
    therapeutics.
  • Saudi Arabia and South Africa dominates the
    Middle East Africa preventive and therapeutic
    vaccine market. RD funding for diseases, such as
    HIV and cancer, by the government offers a novel
    opportunity for the vaccine market. Wide usage of
    vaccines includes, inactivated, live attenuated,
    toxoid, subunit, conjugate, dendritic cell, and
    synthetic. Preventive vaccine is the leading type
    due to high awareness among people.

5

Browse Full Market Research Report On Preventive
and Therapeutic Vaccine Market _at_
http//bit.ly/2sgImzd Request for an in-depth
table of contents for this report _at_
http//bit.ly/2r8XHR7
6
Stay In Touch Website www.gminsights.com Soci
al Media
About PowerShow.com